ELVN实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (8 Jun 2024 @ 04:00):

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer...

Stats
今日成交量	158 006
平均成交量	355 165
市值	984.95M
EPS	$-0.540 ( Q1 \| 2024-05-14 )
下一个收益日期	( $-0.580 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-11.97 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0540 (0.26%)

AADI -1.69%

ABCL -4.23%

ABCM 0.04%

ABEO -0.23%

ABIO -0.91%

ABOS 5.22%

ABSI 0.23%

ABUS -4.19%

ABVX 3.66%

ACAD -2.68%

ACER -17.95%

ACET -3.57%

ACGN 1.29%

ACHL 0.21%

ACHV -0.09%

ACIU -2.05%

ACLX -1.09%

ACRV -1.23%

ACST -4.67%

ACXP 1.27%

ADAG -0.34%

ADAP -0.97%

ADGI 0.87%

ADIL -1.75%

ADMA -1.04%

ADPT -7.44%

ADTX -1.03%

ADVM -1.34%

ADXN -1.85%

AEON 2.44%

AEZS 1.12%

AFMD -2.69%

AGEN 0.24%

AGIO -0.40%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW 0.00%

AKBA -0.93%

AKRO 7.92%

AKTX 1.83%

AKUS 0.00%

ALBO 0.00%

ALDX -2.53%

ALEC -0.23%

ALGS -6.56%

ALKS -1.03%

ALLK 0.87%

ALLO -3.73%

ALLR -9.71%

ALNA 3.16%

ALNY 2.33%

ALPN 0.00%

ALPX 0.00%

ALRN -1.52%

ALT -4.09%

ALVR -2.55%

ALXN 0.00%

ALXO -2.91%

ALZN 0.00%

AMRN -4.51%

AMTI -3.13%

ANAB -2.01%

ANEB -1.36%

ANGN 0.00%

ANIX 8.05%

ANL -18.82%

ANNX -2.55%

ANPC -3.15%

APGE -1.01%

APGN 8.48%

APGNW 30.65%

APLM -9.28%

APLS -1.66%

APLT 3.78%

APM -4.56%

APOP 0.38%

APRE -1.31%

APTO -2.09%

APTX 3.17%

APVO -6.71%

ARAV -13.39%

ARCT -25.31%

ARDS -3.31%

ARDX -4.30%

ARGX -2.84%

ARNA 0.00%

ARPO -0.90%

ARQT -4.74%

ARTL 0.59%

ARTLW -23.66%

ARVN -3.65%

ARWR -3.16%

ASLN -8.32%

ASMB -9.33%

ASND -0.96%

ATAI -6.08%

ATHA 0.39%

ATHE 0.01%

ATHX -33.50%

ATNF -6.90%

ATOS -1.57%

ATRA -7.08%

ATXI -6.11%

ATXS -0.23%

AUPH -1.67%

AURA 0.54%

AUTL -6.54%

AVBP 1.09%

AVEO 0.00%

AVIR -2.63%

AVRO 4.11%

AVTE 4.17%

AVTX -5.20%

AVXL -3.97%

AXLA 0.00%

AXSM -1.15%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO -0.26%

BCAB -7.88%

BCDA -14.87%

BCDAW 57.25%

BCEL 7.44%

BCLI -0.48%

BCRX -2.02%

BCTX -2.80%

BCTXW -8.40%

BCYC -0.35%

BDRX -5.94%

BDTX 11.61%

BEAM -3.57%

BFRA -2.91%

BGNE -0.79%

BIOR -6.34%

BIVI -8.86%

BLCM -6.68%

BLI -5.88%

BLPH 2.31%

BLRX -5.59%

BLTE -0.47%

BLU 0.03%

BLUE -1.04%

BMEA -63.27%

BMRN -0.20%

BNOX 0.71%

BNTC -1.07%

BNTX -1.44%

BOLD 3.22%

BOLT 1.48%

BPMC -1.03%

BPTH -10.79%

BPTS -13.47%

BRNS 2.58%

BRTX -1.69%

BTAI -4.39%

BTTX 1.05%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 2.09%

CABA -4.36%

CADL 0.42%

CALA 0.00%

CALC 0.20%

CALT -4.64%

CAPR -4.38%

CARA -2.79%

CARM -2.70%

CASI -5.71%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -2.34%

CCCC -1.27%

CCXI 0.00%

CDAK 0.00%

CDIO -0.59%

CDIOW -1.03%

CDMO -0.87%

CDMOP 0.04%

CDT 1.07%

CDTTW -25.00%

CDTX -4.04%

CDXC 11.89%

CDXS -7.39%

CELC -0.42%

CELU 0.31%

CELUW 57.89%

CERC -1.68%

CERE -0.60%

CERO -10.94%

CEROW 16.39%

CFRX -27.95%

CGEM -0.62%

CGEN -1.86%

CGON 0.00%

CGTX 5.98%

CHMA -6.00%

CHRS -2.87%

CINC 0.00%

CING 0.67%

CINGW -19.68%

CKPT 0.00%

CLBS -16.75%

CLDX 0.48%

CLGN -3.39%

CLLS -3.75%

CLNN 5.93%

CLNNW 0.00%

CLRB 9.90%

CLSD 2.52%

CLSN -0.68%

CLVS 0.00%

CMMB -9.73%

CMND -0.72%

CMPI 0.00%

CMPX 0.00%

CMRA 0.00%

CMRAW 0.00%

CMRX -0.66%

CNCE 0.00%

CNSP -5.61%

CNST 0.00%

CNTA -1.35%

CNTB 16.67%

CNTX -2.29%

COCP -2.32%

COEPW -33.33%

COGT -0.24%

CORT -3.39%

COYA 3.01%

CPRX -0.89%

CRBP -5.30%

CRBU -6.70%

CRDF -1.68%

CRGX -0.17%

CRIS -8.49%

CRNX -2.47%

CRSP -3.49%

CRTX 2.63%

CRVO -0.36%

CRVS -3.33%

CSBR -3.97%

CTCX 0.79%

CTIC 0.06%

CTMX -1.80%

CTNM 1.18%

CTXR -3.51%

CUE -8.64%

CVAC -10.02%

CVKD -4.95%

CWBR 0.65%

CYAD -12.96%

CYCC 1.01%

CYCCP -3.75%

CYCN -4.14%

CYT -2.27%

CYTK 0.98%

CYTO -4.03%

DARE 18.64%

DAWN -0.85%

DBTX -0.81%

DBVT -10.93%

DFFN 10.28%

DICE 0.06%

DMAC -6.23%

DNLI -2.53%

DNTH -3.82%

DOMH -1.24%

DRMA -5.44%

DRMAW -1.20%

DRNA 0.00%

DRTS -3.56%

DRTSW 0.04%

DRUG 2.75%

DSGN -5.87%

DTIL -2.71%

DYAI -8.18%

EARS -1.77%

EDIT -2.39%

EDSA -0.44%

EFTR -5.07%

EFTRW -48.73%

EIGR 0.00%

ELAB -2.16%

ELDN 2.21%

ELEV -4.08%

ELOX -0.67%

ELTX -3.09%

ELVN 3.66%

ELYM 4.72%

ENGN 7.73%

ENGNW 3.23%

ENLV -2.90%

ENOB 1.79%

ENSC 0.06%

ENTA 2.95%

ENTO -6.77%

ENTX -4.31%

ENVB 1.06%

EPIX -1.72%

EPRX 0.37%

EPZM 0.00%

EQ -10.69%

EQRX -2.09%

EQRXW 0.00%

ERAS 0.85%

ERNA -3.50%

ERYP 1.30%

ESLA -3.69%

ESLAW 0.00%

ETNB 0.06%

ETON -0.82%

ETTX 0.00%

EVAX -4.24%

EVGN 2.19%

EVLO 0.00%

EWTX 0.28%

EXAI -8.66%

EXEL -1.35%

EYEG -0.79%

EYEN -2.56%

EYPT -1.83%

FATE -3.16%

FBIO 1.12%

FBIOP 0.36%

FBLG -6.98%

FBRX 1.94%

FDMT 0.66%

FENC 0.15%

FGEN -7.56%

FHTX -3.53%

FIXX 0.77%

FMTX 0.00%

FNCH -1.41%

FOLD -2.14%

FREQ 4.76%

FRLN 0.15%

FRTX 5.80%

FSTX 0.00%

FTRE -3.98%

FULC -0.96%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -1.89%

GANX -5.98%

GBIO -1.81%

GBT 0.01%

GDTC -6.70%

GERN 17.99%

GHRS -1.39%

GLMD -4.68%

GLPG -1.07%

GLSI -3.43%

GLTO -4.61%

GLUE -5.01%

GLYC -1.11%

GMAB -2.73%

GMDA 0.00%

GMTX 0.00%

GNCA -85.71%

GNFT 4.42%

GNLX -9.52%

GNPX -10.42%

GNTA 4.10%

GOSS -8.60%

GOVX -6.40%

GOVXW 5.06%

GPCR -4.60%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -3.59%

GRTX 0.00%

GTHX 1.35%

GUTS -4.79%

GXGXW 41.67%

GYRE 3.07%

HALO -1.15%

HARP 0.09%

HCWB 0.04%

HEPA 1.85%

HGEN -84.62%

HILS 5.66%

HLVX -1.53%

HOOK 1.11%

HOTH -6.03%

HOWL -0.29%

HRMY -0.07%

HRTX -0.83%

HSTO -1.64%

HUMA -0.68%

HUMAW -7.34%

IBRX 0.16%

ICCC -1.32%

ICPT 0.21%

ICU 2.28%

ICUCW 6.78%

ICVX -0.91%

IDRA -23.04%

IDYA -4.09%

IFRX 0.00%

IGMS 0.12%

IKNA -0.57%

IKT -1.74%

IMAB 1.08%

IMCR -2.37%

IMGN 0.02%

IMGO 0.00%

IMMP -6.32%

IMMX -1.46%

IMNM 0.33%

IMNN -3.05%

IMPL -27.27%

IMRA 15.96%

IMRN -2.19%

IMRX -2.84%

IMTX -2.45%

IMTXW -3.65%

IMUX -0.81%

IMV 0.00%

IMVT -1.02%

INAB 18.58%

INBX 2.52%

INCY 1.28%

INDP 0.00%

INFI -52.38%

INKT -1.61%

INM -7.69%

INMB -2.12%

INO -4.29%

INSM -0.56%

INTS 0.21%

INVA -1.41%

INZY -3.74%

IOBT -1.36%

IONS -2.31%

IOVA -4.42%

IPA 0.51%

IPHA 3.58%

IPSC -2.65%

IRON 7.30%

ISEE 0.38%

ITOS -0.60%

ITRM -2.13%

IVA -2.75%

IVVD -3.43%

JAGX -5.25%

JANX 3.69%

JAZZ 5.39%

JNCE 0.00%

JSPR -3.50%

JSPRW 0.00%

JUNS 0.00%

JUNSW 0%

KA -6.69%

KALV -1.43%

KDNY 0.22%

KMPH -0.34%

KNSA -2.36%

KNTE -0.38%

KOD -3.99%

KPRX 8.80%

KPTI -1.31%

KRBP -15.38%

KRON 2.13%

KROS 0.00%

KRRO 3.71%

KRTX 0.03%

KRYS -0.76%

KTRA -18.11%

KTTA 0.00%

KTTAW 0.00%

KURA -1.36%

KYMR 0.27%

KYTX -3.03%

KZIA -1.73%

KZR 1.44%

LABP 0.57%

LBPH -1.07%

LBPS 0.00%

LBPSW 14.81%

LEGN -2.13%

LENZ 3.59%

LEXX -4.11%

LEXXW 2.68%

LGND -1.23%

LGNDV 0.00%

LGVN -0.95%

LIAN 0.00%

LIFE 2.70%

LIPO 0.55%

LIXT -17.58%

LIXTW -22.02%

LJPC -0.32%

LMNL 0.12%

LOGC -0.72%

LPCN 6.21%

LPTX -0.44%

LQDA -1.08%

LRMR 0.95%

LSTA 4.15%

LTRN -3.96%

LUMO -0.40%

LVTX 1.78%

LXEO -1.15%

LXRX 0.00%

LYEL -2.02%

LYRA 0.13%

MACK 0.00%

MBIO -4.19%

MBRX -3.14%

MCRB -28.03%

MDGL 1.24%

MDNA -13.16%

MDWD 0.71%

MDXG -1.68%

MEIP 0.00%

MESO 4.69%

MGNX -3.00%

MGTA -7.74%

MGTX -2.05%

MGX -8.30%

MIRM 0.44%

MIRO 0.59%

MIST -1.35%

MITO 0.00%

MLEC -5.13%

MLECW 0.00%

MLND -5.36%

MLTX -1.81%

MLYS -2.30%

MNKD 0.54%

MNMD 0.49%

MNOV -1.44%

MNPR -12.70%

MOLN -3.78%

MOR -2.39%

MORF 0.69%

MREO -0.58%

MRKR 4.20%

MRNA -2.38%

MRNS 1.33%

MRSN -3.39%

MRTX -0.17%

MRUS -1.51%

MRVI 1.77%

MTCR -1.29%

MTEM -9.92%

MTP -18.50%

MURA 0.30%

MYMD 2.09%

NAMS -1.53%

NAMSW -12.50%

NAUT -2.99%

NBRV 0.71%

NBSE -1.56%

NBTX -8.06%

NCNA -9.93%

NERV -4.17%

NEXI -5.36%

NGM -1.28%

NGNE 1.94%

NKGN 5.84%

NKGNW 4.65%

NKTR -9.35%

NKTX -1.64%

NLSP -5.69%

NLSPW -5.48%

NMRA 0.20%

NMTR -42.97%

NOVN -24.84%

NRBO -1.26%

NRIX -3.98%

NRSN -3.51%

NRSNW 23.47%

NRXP -5.59%

NRXPW 20.00%

NRXS -0.33%

NTBL -5.52%

NTEC -12.45%

NTHI 0%

NTLA -0.96%

NTRBW -25.76%

NUVL -2.98%

NVAX -7.08%

NVCT -2.91%

NVIV -34.28%

NXTC 13.01%

NYMX -0.05%

OABI 0.43%

OABIW 5.59%

OBIO -0.13%

OBSV 0.00%

OCEA -0.69%

OCGN -7.51%

OCS -0.92%

OCUL -5.00%

OCUP -1.17%

ODT -4.27%

OKYO -9.93%

OLMA -1.20%

OMER -1.28%

OMGA -1.48%

ONCO -8.82%

ONCR -3.08%

ONCS 31.87%

ONCT -3.87%

ONCY -0.94%

ONTX -0.47%

ONVO 0.02%

OPNT 0.00%

OPT -3.10%

ORGS -4.10%

ORIC -1.12%

ORMP -3.67%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -3.55%

OVID -4.52%

OYST 0.00%

PALI -2.56%

PASG -4.44%

PBLA -3.12%

PBM -3.74%

PBYI -0.98%

PCSA -6.78%

PCVX -2.12%

PDSB 0.52%

PEPG -4.44%

PGEN -5.26%

PHAR -4.63%

PHAS 0.00%

PHAT 9.50%

PHIO 0.95%

PHIOW 36.47%

PHVS -6.78%

PHXM -5.20%

PIRS 1.49%

PKBO 0.00%

PKBOW 0.00%

PLRX -3.38%

PLUR 3.02%

PMN 2.91%

PMVP 0.61%

PNT 0.16%

PPBT -7.17%

PRAX -7.51%

PRDS 0.93%

PRLD -0.79%

PROG -3.47%

PROK -11.39%

PRQR -7.04%

PRTA -2.54%

PRTC 0.84%

PRTG -9.52%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -5.24%

PSTX -2.89%

PTCT -1.11%

PTE -0.82%

PTGX 2.29%

PTIXW 143.75%

PULM 4.23%

PXMD -5.45%

PYPD -3.11%

PYXS 7.34%

QLGN -9.09%

QNCX -5.99%

QNRX -1.37%

QSI -4.52%

QSIAW -0.05%

QTTB -0.77%

QURE 0.38%

RAIN -1.63%

RANI -3.09%

RAPT -4.71%

RARE -0.89%

RCKT -1.35%

REGN 0.22%

RENB -3.01%

REPL 11.11%

RETA 0.02%

REUN -0.89%

REVB -3.08%

REVBU 3.46%

REVBW 8.53%

RGLS 0.00%

RGNX 2.33%

RIGL -1.01%

RLAY 8.67%

RLMD -2.96%

RLYB -0.67%

RNA 2.15%

RNAC 5.42%

RNAZ -17.91%

RNXT -1.92%

ROIV -1.41%

ROIVW 4.56%

RPHM -1.76%

RPRX 1.37%

RPTX -2.51%

RUBY 2.70%

RVLP -32.05%

RVMD 0.47%

RVMDW -17.67%

RVNC -6.90%

RVPH 0.00%

RVPHW -11.54%

RXDX 0.09%

RXRX -5.55%

RYTM 0.73%

RYZB 0.02%

RZLT 2.33%

SABS -1.22%

SABSW 15.48%

SAGE -1.76%

SANA -5.16%

SAVA -1.55%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -25.94%

SCPH -3.35%

SCPS 0.00%

SEEL -4.89%

SEER -1.70%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -2.94%

SGMT 1.08%

SGTX -2.56%

SIOX 22.63%

SLDB 4.40%

SLGL 5.84%

SLN 0.89%

SLNO 2.06%

SLRX -6.59%

SLS -1.36%

SMMT -5.04%

SNDX 0.52%

SNGX -8.92%

SNPX -1.42%

SONN 2.41%

SPPI -0.49%

SPRB 0.45%

SPRC -4.61%

SPRO -3.10%

SRNE 0.00%

SRPT 5.01%

SRRA 0.00%

SRRK 0.85%

SRZN 6.38%

STAB 0.00%

STOK -2.30%

STRO -1.33%

STSA 0.00%

STTK -3.31%

SURF -0.93%

SVRA -1.49%

SWTX 1.28%

SYBX -1.86%

SYRS -2.83%

TALS -0.73%

TARA -1.48%

TARS -0.28%

TBPH -1.24%

TCBP -7.69%

TCDA 0.00%

TCON -3.39%

TCRR 0.00%

TCRT -2.91%

TCRX -3.23%

TECH -1.52%

TENX -2.54%

TERN -1.79%

TFFP -3.30%

TGTX 0.25%

THRX 0.12%

TIL -0.28%

TLC 0.00%

TLSA 0.00%

TNGX -4.17%

TNXP -4.32%

TNYA -0.82%

TPST -2.81%

TRDA -0.38%

TRVI -1.21%

TRVN -0.84%

TSHA 2.33%

TSVT -5.21%

TTNP 7.63%

TVTX -1.38%

TYRA -0.10%

UBX -1.54%

UNCY 0.74%

URGN 0.15%

UTHR -0.51%

VACC 11.36%

VALN 1.37%

VAXX 5.88%

VBIV -2.07%

VBLT -8.77%

VCEL -3.12%

VCNX 4.94%

VCYT -3.55%

VERA 1.26%

VERU -0.35%

VERV -1.33%

VIGL 7.48%

VINC -1.26%

VIR -6.26%

VIRI -3.39%

VIRX -2.98%

VKTX 1.78%

VLON -13.04%

VNDA -2.39%

VOR -3.16%

VRCA -6.83%

VRDN -0.49%

VRNA 1.00%

VRPX -6.30%

VRTX -0.51%

VSTM -6.59%

VTGN -1.81%

VTVT -2.84%

VTYX -0.76%

VXRT -3.48%

VYGR -0.71%

VYNE -7.02%

VYNT 7.78%

WINT -4.23%

WVE -3.17%

XBIO -3.69%

XBIT -5.07%

XCUR -16.35%

XENE -0.40%

XERS -1.27%

XFOR -0.98%

XLO 2.94%

XLRN 0.00%

XNCR -0.78%

XOMA 0.29%

XOMAO 0.44%

XOMAP -1.29%

XRTX 0.00%

YMAB -2.68%

ZGNX 0.00%

ZIOP -0.88%

ZLAB 5.26%

ZNTL -4.15%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-05-29	Lyssikatos Joseph P	Sell	12 000	Stock Option (right to buy)
2024-05-29	Lyssikatos Joseph P	Buy	12 000	Common Stock
2024-05-29	Lyssikatos Joseph P	Sell	9 877	Common Stock
2024-05-29	Lyssikatos Joseph P	Sell	2 123	Common Stock
2024-05-28	Kintz Samuel	Sell	12 000	Stock Option (right to buy)

INSIDER POWER
-78.20
Last 99 transactions
Buy: 341 486 \| Sell: 2 695 935

音量相关性

長: -0.10 (neutral)

短: 0.32 (neutral)

Signal:(33.293) Neutral

Enliven Therapeutics, 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Enliven Therapeutics, 相关性 - 货币/商品

-0.43
( neutral )

-0.49
( neutral )

0.00
( neutral )

-0.01
( neutral )

0.00
( neutral )

0.24
( neutral )

Enliven Therapeutics, 财务报表

Annual	2023
营收:	$0
毛利润:	$-297 000 (0.00 %)
EPS:	$-2.01

FY	2023
营收:	$0
毛利润:	$-297 000 (0.00 %)
EPS:	$-2.01

FY	2022
营收:	$0
毛利润:	$-622 000 (0.00 %)
EPS:	$-12.08

Financial Reports:

No articles found.

Enliven Therapeutics, Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Enliven Therapeutics,

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its pipeline of small molecule kinase inhibitors include ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial has been activated to evaluate people with cancers harboring an abnormal HER2 gene. The company is based in Boulder, Colorado.